MD Anderson is the leading hospital in the nation for cancer care for the fourth year straight, according to the annual “America’s Best Hospitals” survey published in U.S. News & World Report’s August issue. Six subspecialties at MD Anderson also ranked highly: ear, nose and throat (6); urology (10); gynecology (11); pediatrics (12); gastroenterology (19); and diabetes and endocrinology (21). The 2010 results mark the seventh time in the past nine years that MD Anderson has ranked No. 1. Since 1990, the institution has ranked as one of the top two cancer hospitals in the United States.
“This achievement is due to the dedication and hard work of everyone who is part of the MD Anderson team, including the members of our Board of Visitors and Advance Team,” says John Mendelsohn, M.D., president of MD Anderson.
The institution received funds from two new government sources this year: $53.8 million over two years through the American Recovery and Reinvestment Act, and $29 million from the state of Texas’ Cancer Prevention and Research Institute of Texas.
MD Anderson’s $1 billion Making Cancer History®: The Campaign to Transform Cancer Care, publicly launched in February 2010, has raised $834.6 million to date for cancer prevention and risk assessment; basic science; translational research; personalized therapy; and care quality, safety and effectiveness.